Demyelinating Diseases Roop/Raja Flashcards

1
Q

A 35 year-old-woman visits her primary physician with a CC of difficulty in walking. She said this occurred for five days last month, and she has experienced pain and prickly sensations that come and go, as well as occasional muscle weakness. Vital signs show: Temp.= 97.7 °F, Pulse= 70/min, Resp. = 15/min, BP = 124/80 mmHg, BMI = 27. Physical exams appears w/ muscle strength testing = normal, deep tendon reflexes = normal, patellar tendon reflexes = normal, when asked to walk, she had difficulty in balancing and maintaining a normal gait. What other lab studies would you order to be done on this patient?

A

Electromyography and nerve conduction velocity test

Edrophonium Test (Tensilon)

CSF analysis

MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

A 35 year-old-woman visits her primary physician with a CC of difficulty in walking. She said this occurred for five days last month, and she has experienced pain and prickly sensations that come and go, as well as occasional muscle weakness. Vital signs show: Temp.= 97.7 °F, Pulse= 70/min, Resp. = 15/min, BP = 124/80 mmHg, BMI = 27. Physical exams appears w/ muscle strength testing = normal, deep tendon reflexes = normal, patellar tendon reflexes = normal, when asked to walk, she had difficulty in balancing and maintaining a normal gait. A number of lab studies were done: electromyography test= normal, nerve conduction velocity test = normal, Edrophonium Test (Tensilon ) test= normal, CSF analysis had oligoclonal IgG bands. What are oligoclonal bands and what do they primarily indicate?

A

Oligoclonal bands are proteins called immunoglobulins. The presence of these proteins indicates inflammation of the CNS

Useful aid in diagnosis of MS (primarily), herpes simplex, encephalitis, bacterial meningitis, neurosyphilis, lupus, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

A 35 year-old-woman visits her primary physician with a CC of difficulty in walking. She said this occurred for five days last month, and she has experienced pain and prickly sensations that come and go, as well as occasional muscle weakness. Vital signs show: Temp.= 97.7 °F, Pulse= 70/min, Resp. = 15/min, BP = 124/80 mmHg, BMI = 27. Physical exams appears w/ muscle strength testing = normal, deep tendon reflexes = normal, patellar tendon reflexes = normal, when asked to walk, she had difficulty in balancing and maintaining a normal gait. A number of lab studies were done: electromyography test= normal, nerve conduction velocity test = normal, Edrophonium Test (Tensilon ) test= normal, CSF analysis had oligoclonal IgG bands, MRI – Gadolinium-enhancing brain lesions. What is Gadolinium?

A

A naturally occurring element used to enhance certain lesions

ex: cancer has vasculature so it uptakes GAD, whereas a cyst that does not uptake GAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MS is an immune-mediated inflammatory disease that attacks ____________ axons in the CNS

A

myelinated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the hallmark of MS?

A

symptomatic episodes that occur months or years apart affecting different anatomic locations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MS most commonly begins between ______ years of age, and is more common in ____________

A

20-40, women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MS has localized areas of demyelination called _________ with destruction of oligodendrocytes, primarily in the white matter

A

plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MS has perivascular inflammation & chemical changes in the ________ and _______ components of myelin

A

lipid, protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In MS, what is damaged?

A

axons and cell bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does scleroses mean?

A

hardening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A 35 year-old-woman visits her primary physician with a CC of difficulty in walking. She said this occurred for five days last month, and she has experienced pain and prickly sensations that come and go, as well as occasional muscle weakness. Vital signs show: Temp.= 97.7 °F, Pulse= 70/min, Resp. = 15/min, BP = 124/80 mmHg, BMI = 27. Physical exams appears w/ muscle strength testing = normal, deep tendon reflexes = normal, patellar tendon reflexes = normal, when asked to walk, she had difficulty in balancing and maintaining a normal gait. A number of lab studies were done: electromyography test= normal, nerve conduction velocity test = normal, Edrophonium Test (Tensilon ) test= normal, CSF analysis had oligoclonal IgG bands, MRI – Gadolinium-enhancing brain lesions. What does this pt most likely have?

A

MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What happens to the neuron speed of transmission in MS patients?

A

Wouldn’t have saltatory conduction
-Saltatory conduction → action potential jumping from the nodes of Ranvier (bc of this we have synchronized movements like walking)
-if damaged, then it can lead to muscle weakness or even paralysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the classic signs and symptoms of MS?

A

-sensory loss (early in disease)
-spinal cord symptoms (motor): muscle cramping secondary to spasticity
-spinal cord symptoms (autonomic): bladder, bowel, and sexual dysfunction
-cerebellar triad/symptoms: dysarthria (slurred speech), nystagmus, and intentional tremor
-optic neuritis (inflammation of optic nerve)
-trigeminal neuralgia
-heat intolerance
-fatigue (70% of cases)
-dizziness
-carpal tunnel early on can actually indicate MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How many categories of MS are there? What are they?

A

1) Relapsing-remitting MS (most common)
2) Secondary progressive MS (follows the initial relapsing remitting course)
3) Primary progressive MS
4) Progressive-Relapsing MS (rare)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the etiology of MS?

A

-unknown
-genetic & molecular factors
-viral infection: activates T cells against myelin
-environmental factors: lower MS rates in equatorial regions
-Low levels of vitamin D – low sunlight exposure in temperate areas (MS is not as common in tropical areas)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does the histology look like for MS?

A

-vacuolation as the myelin is destroyed
-arrows in pic indicate macrophages/microglia with ingested myelin (myelin that has been damaged)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

The first step of MS seems to be ____________ molecules interacting with T cells, B cells & macrophages. Later the BBB endothelium is digested away and the cells enter. B cells release immunoglobulins, T cells release inflammatory cytokines/chemokines and _____________ expose axons releasing NO, glutamate & oxygen free radicals.

A

adhesion, macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Acute demyelination falls into 3 categories. What are they?

A

1) Phagocytic cells with perivascular & parenchymal T cell infiltration
2) Everything in category 1 + the presence of complement & antibodies.
3) Oligodendrocyte apoptosis (Oligodendrocytes responsible for myelin in CNS, Schwann cells responsible for myelin in PNS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

In ________ MS, what determines remyelination or not, is not well understood.

A

chronic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

In chronic MS, there is remyelination with a ______ myelin sheath

A

thin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

In chronic MS, inflammation resolves without remyelination = _______ _______

A

chronic inactive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

In chronic MS, inflammation does not resolve and there is a slow demyelination = ___________. This is most common in progressive MS.

A

smoldering

(inflammation is still occurring)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

In Relapsing Remitting MS (RRMS), recurrent attacks resolve or almost completely resolve, over a short period of time. Remission can last for months to years. There is very little _________ deficit. However, today it is theorized that there is progressive neuronal degeneration continuing even during the periods of remission.

A

residual

24
Q

Today treatment modalities slow the progress of relapsing remitting MS (RRMS), but within 10-15 years of the onset of the disease, _____% of patients will convert to secondary progressive MS (SPMS). SPMS is an increasing disability with little response to today’s drugs.

A

50

25
Q

In 10-15% of cases of primary progressive MS (PPMS) there is a steady decline in function. There are no __________ & no clear exacerbations.

A

remissions

26
Q

In progressive relapsing MS (PRMS), there is a progressive decline with ________ relapses. Also, this is the rarest MS category

A

occasional

27
Q

What is the treatment for MS?

A

-Methylprednisolone for acute exacerbations
-disease modifying agents for MS (DMAMS)
»primarily w/ RRMS
»reduces frequency and severity for clinical attacks
»includes interferons and monoclonal Abs
-interferons reduce the frequency of clinical exacerbations and decreases the lesion volume/number
-treatment slows progression
-immunotherapies
-Plasmapheresis (costly process, not commonly done in US bc insurance doesn’t want to cover it)
-PT, OT, speech therapy

28
Q

MS has an unknown trigger that sets up the initial focus of inflammation in the brain and _____ becomes locally permeable to leukocytes and blood proteins. T cells specific for CNS antigens and are activated in peripheral lymphoid tissues that reencounter antigen presented on __________ or ______ in brain. Inflammatory reaction occurs in the brain due to mast cell activation, complement activation, Abs, and cytokines. This results in the demyelination of neurons.

A

BBB, microglia, DCs

29
Q

What are the risk factors for MS?

A

-Previous viral infections
»EBV has molecular mimicry and there are Abs against EBV attacking the myelin sheath
»Herpes(HHV-6 specifically)
-Low vitamin D
»over-activating Th cells releasing IFN-gamma
»pushing T cells to become activated
-Genetics
»changes in the HLA-DRB1 gene affects MHC
-brain should be a privileged site, unknown on how MS breaches BBB
-metabolism, diet, and obesity

30
Q

What are the immune cells involved in the problem
with MS?

A

-B cells make Abs against myelin sheath
-Th1 produces IFN-gamma which degranulates mast cells and recruits neutrophils
-Th17 produces IL23
-CD8 T cells kill oligodendrocytes when they’re presented by a microglia cell or DC
-GM-CSF (granulocyte-macrophage colony stimulating factor) proliferates activated monocytes, macrophages, and granulocytes
-DCs w/ CCR5 or CCR7 which tells them to migrate

31
Q

What role do CD4+ T cells have with MS?

A

-CD4+ T cells in MS pathogenesis
»IFN-gamma is produced by Th1 cells and IL17 produces Th17 cells which are found in active MS lesions within the CNS
»Th17 cells can weaken the integrity of the BBB and thereby promote further inflammation
»CD4+ T cells can migrate to and damage neurons directly within the grey matter (associated w/ neuronal decline and neurodegeneration)

32
Q

What role do CD8+ T cells have with MS?

A

-CD8+ T cells dominate the T cell infiltrates in active MS lesions and are subsequently reduced in the circulation
-CD8+ T cells in MS lesions exhibit a tissue resident memory phenotype and show markers of activation as well as expression of the pro-inflammatory cytokine IL17

33
Q

What role do B cells have with MS?

A

These clonally expanded and antigen-experienced B cells recognize ubiquitous intracellular and seemingly non-pathogenic self proteins

34
Q

What role do monocytes have with MS?

A

recruitment of monocytes into CNS is controlled by the presence of the growth factor GM-CSF, which is produced by auto-reactive T cells

35
Q

What role do DCs have with MS?

A

-Conventional DCs show a dysregulated pro-inflammatory phenotype, enhanced production of IL12 and IL23, as well as increased expression of chemokine receptors CCR5 and CCR7 permitting their migration to the CNS
-The role of IL12 production by DCs and other APCs is pivotal for the generation of TH1 cells and cytotoxic CD8+ T cell expansion, and in promoting auto-reactive TH1 cell and CD8+ T cell populations in MS

36
Q

What is the target of MS?

A

-Antigen-specific immune response (CD4 T-cell) is generated against proteins of the CNS towards the myelin sheath that protects the axons of neurons
»Components of the myelin sheath (for example, myelin basic protein (MBP), myelin oligodendrocyte
glycoprotein (MOG) or proteolipid protein (PLP)) are the main targets for autoimmune attack
-Antibodies against the Epstein–Barr virus (EBV) and nuclear antigen 1 (EBNA1) have been recognized to cross-react with glial cell adhesion molecule (GlialCAM), a protein expressed by CNS-resident glial cells.
-Cytokine release and autoimmune brain inflammation can be induced independently of specific antigens.
-The clinical course of MS and the affected brain areas can vary dramatically between patients, it is likely that any antigen-specific immune response will not be acting alone
-Do not want cytokines to be released in BBB
»If there is cytokines = inflammation

37
Q

What is the disease progression of MS?

A

Very early in disease
-Widespread inflammatory infiltrates, populations of CD4+ T cells, CD8+ T cells, B cells and monocytes.
-The subsequent destruction of myelin-producing oligodendrocytes by these cells leads to the formation of acute lesions in early disease stages
-Demyelinated axons and axonal damage will occur, and the neuronal body is also affected. This indicates that neuronal loss, a defining feature of disease progression, is also present in early stages of the disease.

Progressive Disease
-Inflammation in the form of chronic active lesions that exhibit a thinner margin of activated microglia, and few myelin-containing macrophages is still frequent in patients with progressive disease
-Notably, MS-associated inflammation disturbs the protein homeostasis of neurons, resulting in a formation of protein aggregates that directly contribute to neuronal injury. This leads to the progression of neuronal degeneration in MS

38
Q

What are the disease modifying therapies (specifically immune system modulators) in MS?

A

-S1P receptor modulators: Sequester lymphocytes in lymph node
-Agents that stop T-cell and B-cell proliferation
-Prevent entry of lymphocytes into CNS
-Push T-cell into T-reg state
-Interferons
-Prednisone inhibits NFkB so it cannot produce pro-inflammatory cytokines
-Cladribine is an adenosine analog that ensures adenosine binds on A2AR and keeps it in T reg state so that T cells don’t differentiate
-Natalizumab (tysabri) is the most commonly used drug against MS and reduces migration of lymphocytes across the BBB and is an inhibitor of selective adhesion molecules (VCAM), preventing extravasation of immune cells into privileged areas like the brain
-Ocrelizumab (ocrevus) depletes CD20 B cells (against CD20 to stop it from differentiating so it doesn’t become plasma cells that release the problematic Abs)
-Fingolmod is an antagonist of the sphingosine-1-phosphate (S1P) receptor which is highly expressed in leukocytes and causes T cells to be sequestered in the lymph nodes and reduces the number of circulating T cells (stops movement of T cells and arrests the thymus so that it doesn’t go to peripheral area), also this will need to be coupled with another drug
-dimethyl-fumarate pushes the system to an oxidative environment so that immune cells don’t get activated

39
Q

T/F: Neuromyelitis Optica Spectrum Disorder (Devic’s Disease, NMOSD) was once considered a variant of MS, but now classified as its own disease entity

A

true!!!

40
Q

What is NMOSD, and what symptoms result in it still being misdiagnosed as MS?

A

rare inflammatory disease that most often affects the optic nerves and spinal cord. Less often, it affects the brain. It often leads to sudden vision loss, paralysis or both. Symptoms after a first attack usually improve

41
Q

NMOSD causes __________ __________ (sometimes bilateral) resulting in loss of vision in the horizontal half of the visual field and demyelination of the ____________ or ___________ spinal cord

A

optic neuritis, cervical, thoracic

42
Q

NMOSD consists of muscle spasms, incontinence, and….

A

paraparesis or quadriparesis

43
Q

What is the pathophysiology of NMOSD?

A

-body produces Abs (anti-AQP4) against aquaporin-4 (AQP4)
-Abs found in approx. 73% of NMOSD pts (not found in MS)
-AQP4 is the most widely expressed water channel in the brain, spinal cord, and optic nerves (also present in the collecting ducts of the kidney, parietal cells of the stomach, airways, secretory glands, and skeletal muscle)
-in the CNS, AQP4 is found primarily in the foot processes of astrocytes
-Abs get through the BBB and bind to AQP4 receptors on the astrocytes and initiate complement and inflammation
-Neutrophils and eosinophils are abundant
-Damaged astrocytes can no longer support neurons or oligodendrocytes and demyelination occurs
-Unlike MS, demyelination is secondary to astrocytic damage

44
Q

How does NMOSD differ from MS?

A

NMOSD indirectly demyelinates myelin (secondary to astrocytic damage), while MS is direct demyelination (primary)

45
Q

What is the treatment for NMOSD?

A

-high dose steroids
-immunosuppressants
-untreated, approx. 50% of NMOSD pts will be wheelchair bound and blind
-untreated, 1/3 of NMOSD pts die within 5 years of their first attack

46
Q

NMOSD primarily affects who?

A

Africans and asians

47
Q

This is not an antigen used to treat MS:
A) ipilmumab
B) cladribine
C) rituximab
D) interferons

A

A) ipilmumab

48
Q

The most common type of MS is….

A

relapsing remitting MS

49
Q

This is not an immune cell often seen in MS:
A) TH2 cell
B) CD8 T cell
C) B cell
D) TH17 cell
E) monocytes

A

A) TH2 cell

50
Q

One of these serves as a target for an immune reaction in MS:
A) NK response against the myelin basic protein (MBP)
B) antibodies against streptococcus antigen
C) antibodies against the nuclear body of the axon
D) antibodies that cross react with the glial cell adhesion molecule

A

D) antibodies that cross react with the glial cell adhesion molecule

51
Q

Within 10-15 years of the onset of this disease, patients with RRMS will convert to….

A

SPMS

52
Q

This is a risk factor for MS:
A) streptococcus infection
B) COVID
C) human herpesvirus infection
D) cardiovascular disease

A

C) human herpesvirus infection

53
Q

A 35 y/o woman comes to her PCP complaining of difficulty in walking. An MRI indicated Gd-enhancing brain lesions. Analysis of CSF showed an oligoclonal IgG band. During the initial stages of this disease, how would the velocity of action potential transmission be altered within the CNS?

A

myelinated axons would show a decreased conduction velocity, unmyelinated axons would show no change in conduction velocity

54
Q

____________ are primarily affected in NMOSD, while ______________ are primarily affected in MS

A

astrocytes, oligodendrocytes

55
Q

Antibodies to which of the following are found in 73% of NMOSD patients?
A) GM1
B) LM1
C) MOG
D) aquaporin 4

A

D) aquaporin 4

56
Q

Natalizumab’s taget is….

A

a cell adhesion molecule in the BBB